Sandy Spring Bank »

Adaptimmune Therapeutics shares owned by Sandy Spring Bank

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Sandy Spring Bank from 13F filings

Historical chart of Sandy Spring Bank investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Sandy Spring Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Sandy Spring Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $832 1.1k 0.79
2023-09-30 $819 1.1k 0.78

More positions owned by Sandy Spring Bank

Ishares S&p Midcap 400 Index Core S&p Mcp Etf (IJH)
Ishares S&p 500 Index Fund Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares S&p Smallcap 600 Index Fund Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Trust Tr Unit (SPY)
Midcap 400 Spdr Trust Series 1 Utser1 S&pdcrp (MDY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Core S&p Value Etf Core S&p Us Vlu (IUSV)
Ishares Core S&p Us Growth Core S&p Us Gwt (IUSG)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Midcap Divid (DON)
Berkshire Hathaway Inc B Cl B New (BRK.B)

View all positions for Sandy Spring Bank

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
GSA Capital Partners
Acuitas Investments
Millennium Management
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics